Michael Gelband’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,544
Closed -$1.79M 1929
2026
Q1
$1.79M Buy
+53,544
New +$2.24M 0.01% 821
2025
Q4
Sell
-24,165
Closed -$736K 1924
2025
Q3
$736K Buy
+24,165
New +$743K 0.01% 1066
2025
Q2
Sell
-119,175
Closed -$4.17M 1845
2025
Q1
$4.17M Buy
119,175
+30,201
+34% +$1.2M 0.04% 464
2024
Q4
$3.96M Buy
88,974
+48,623
+121% +$2.18M 0.03% 504
2024
Q3
$1.76M Buy
+40,351
New +$1.52M 0.01% 786
2024
Q1
Sell
-80,684
Closed -$3.04M 1839
2023
Q4
$3.04M Buy
80,684
+41,739
+107% +$1.53M 0.02% 459
2023
Q3
$1.75M Buy
+38,945
New +$2.36M 0.02% 714
2023
Q2
Sell
-18,998
Closed -$1.11M 2142
2023
Q1
$1.11M Sell
18,998
-11,883
-38% -$655K 0.01% 1105
2022
Q4
$1.56M Buy
30,881
+14,649
+90% +$880K 0.02% 756
2022
Q3
$1.41M Buy
+16,232
New +$1.71M 0.02% 956
2022
Q2
Sell
-2,018
Closed -$261K 2295
2022
Q1
$261K Buy
+2,018
New +$291K ﹤0.01% 1814
2021
Q1
Sell
-12,913
Closed -$1.55M 2466
2020
Q4
$1.55M Buy
+12,913
New +$1.27M 0.02% 650
2020
Q3
Sell
-8,472
Closed -$598K 2099
2020
Q2
$598K Buy
+8,472
New +$580K 0.02% 985
2019
Q3
Sell
-4,075
Closed -$351K 1549
2019
Q2
$351K Sell
4,075
-84
-2% -$6.83K 0.01% 616
2019
Q1
$336K Buy
+4,159
New +$311K 0.03% 436

Other funds holding OMCL

Michael Gelband's OMCL Position: Q2 2026 in Review

Michael Gelband sold out of Omnicell (OMCL) in Q2 2026, closing a stake of 53,544 shares — an estimated $1.79M sold.

Michael Gelband first reported a position in OMCL in Q1 2019 and held it in 15 quarters. The position peaked at $4.17M in Q1 2025. 304 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Michael Gelband reported no remaining Omnicell position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 53,544 Omnicell shares in Q2 2026, an estimated $1.79M.
  • Michael Gelband first reported a position in Omnicell in Q1 2019 and held it in 15 quarters.
  • Michael Gelband's Omnicell position peaked at $4.17M in Q1 2025.
  • 304 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.